The
St. Kitts Biomedical Research Foundation (SKBRF) is a research and development organization devoted to providing predictive preclinical research models and services to accelerate therapeutic candidate evaluation and reduce the risk of clinical failure. SKBRF, with its partner company, Virscio, engages with leading pharmaceutical, biotechnology and academic sponsors and collaborators around the world to design and execute a wide range of translational studies and research programs across multiple therapeutic areas. SKBRF’s goal is to apply the St. Kitts green monkey - a unique and valuable biological resource – to provide the most robust possible preclinical understanding of the efficacy and safety of novel therapies, medical devices and delivery technologies, and advance understanding of disease pathophysiology. SKBRF is committed to achieving meaningful advances in human health through humane, sustainable and efficiency nonhuman primate research. Our team and work environment have been assembled and developed to achieve these goals, while maintaining utmost respect for animal welfare, our employees and the continued success of our collaborators and clients.